Published in Am J Transplant on May 13, 2009
Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker. Am J Transplant (2011) 1.71
Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. Nephrol Dial Transplant (2012) 1.55
Looking for the needle in the kidney transplantation haystack. Clin Kidney J (2017) 1.40
Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88
Immune Monitoring as Prerequisite for Transplantation Tolerance Trials. Clin Exp Immunol (2017) 0.84
Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation. PLoS One (2012) 0.84
Assessment of kidney organ quality and prediction of outcome at time of transplantation. Semin Immunopathol (2011) 0.82
Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose. Br J Clin Pharmacol (2010) 0.82
Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival. J Am Soc Nephrol (2015) 0.81
Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat. PLoS One (2012) 0.81
Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions. Expert Opin Drug Metab Toxicol (2011) 0.80
Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism. J Proteome Res (2012) 0.79
Oxidative stress is associated with weight gain in recipients at 12-months following kidney transplantation. Clin Biochem (2015) 0.75
Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients. Dis Markers (2015) 0.75
KAP degradation by calpain is associated with CK2 phosphorylation and provides a novel mechanism for cyclosporine A-induced proximal tubule injury. PLoS One (2011) 0.75
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation. PLoS One (2017) 0.75
Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature. Clin Pharmacokinet (2017) 0.75
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med (2007) 5.31
Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2009) 5.26
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02
Costimulation blockade with belatacept in renal transplantation. N Engl J Med (2005) 4.86
Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med (2006) 4.79
Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35
Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med (2008) 4.32
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04
Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med (2008) 4.04
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant (2008) 2.81
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76
Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol (2007) 2.64
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Am J Transplant (2007) 2.46
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Lancet (2004) 2.38
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Kidney paired donation and optimizing the use of live donor organs. JAMA (2005) 1.82
A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg (2008) 1.74
ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation (2009) 1.71
Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia. Am J Transplant (2006) 1.47
Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant (2005) 1.47
Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol (2008) 1.46
BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol (2008) 1.13
Transplantation across previously incompatible immunological barriers. Transpl Int (2006) 1.07
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol (2008) 1.06
Clinical transplantation tolerance: many rivers to cross. J Immunol (2007) 1.01
ABO-incompatible kidney transplantation. Transplantation (2004) 0.96
Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation (2004) 0.84
Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc (2001) 3.90
Development and acceptance of medical information systems: an historical overview. J Health Hum Resour Adm (1988) 3.76
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab (1989) 2.03
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results. Chest (1993) 1.89
Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant (2008) 1.73
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Preimplantation diagnosis of single gene disorders by two-step oocyte genetic analysis using first and second polar body. Biochem Mol Med (1997) 1.52
Lies, damn lies, and statistics: the perils of the P value. Am J Transplant (2006) 1.50
Primum non Nocere: is chronic kidney disease staging appropriate in living kidney transplant donors? Am J Transplant (2009) 1.49
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia. Am J Transplant (2006) 1.47
Transvaginal ultrasound in patients with low beta-human chorionic gonadotropin values: how often is the study diagnostic? Ann Emerg Med (1997) 1.47
An abasic site in DNA. Solution conformation determined by proton NMR and molecular mechanics calculations. Nucleic Acids Res (1987) 1.47
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Tumescent anesthesia for dermatologic surgery. Cosmetic and noncosmetic procedures. Dermatol Surg (1998) 1.42
Fetal middle-cerebral and umbilical artery flow assessments after glucose challenge test. Int J Gynaecol Obstet (1999) 1.42
Campylobacter-like organisms in association with symptomatic gastritis in children. J Pediatr (1986) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol (2001) 1.40
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. Am J Transplant (2009) 1.40
Training the novice in laparoscopy. More challenge is better. Surg Endosc (2002) 1.40
A mobile aerosol cryotherapy device (Histofreezer) for treatment of cervical contact bleeding: a pilot study. J Obstet Gynaecol (2003) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
USDA plans for BSE contingency. J Am Vet Med Assoc (1997) 1.38
Sonographic differential diagnosis of persistent ovarian cysts. Ultrasound Obstet Gynecol (1998) 1.38
Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Hum Reprod (1995) 1.38
Organ donation: the gift, the weight and the tyranny of good acts. Am J Transplant (2007) 1.38
Predictive value of history and physical examination in patients with suspected ectopic pregnancy. Ann Emerg Med (1999) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Penetration of the bladder by a perforating intrauterine contraceptive device: a sonographic diagnosis. Ultrasound Obstet Gynecol (1996) 1.32
A tobacco plasma membrane calmodulin-binding transporter confers Ni2+ tolerance and Pb2+ hypersensitivity in transgenic plants. Plant J (1999) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant (2009) 1.19
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Expression of a truncated tobacco NtCBP4 channel in transgenic plants and disruption of the homologous Arabidopsis CNGC1 gene confer Pb2+ tolerance. Plant J (2000) 1.19
Polar body diagnosis of common aneuploidies by FISH. J Assist Reprod Genet (1996) 1.19
Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol Dial Transplant (1999) 1.16
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant (2011) 1.16
Gender differences in the risk for chronic renal allograft failure. Transplantation (2001) 1.14
The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant (2007) 1.13
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin. J Biol Chem (2001) 1.13
Haemolytic-uraemic syndrome and heparin therapy. Lancet (1969) 1.12
A high-affinity calmodulin-binding site in a tobacco plasma-membrane channel protein coincides with a characteristic element of cyclic nucleotide-binding domains. Plant Mol Biol (2000) 1.11
Equilibrium between a wobble and ionized base pair formed between fluorouracil and guanine in DNA as studied by proton and fluorine NMR. J Biol Chem (1988) 1.11
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. Am J Transplant (2009) 1.10
Abdominal pregnancy following in vitro fertilization in a patient with previous bilateral salpingectomy. Obstet Gynecol (1996) 1.10
Hemorrhage into pituitary adenomas. Surg Neurol (1983) 1.09
Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation (2000) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia (2005) 1.06
Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int (2001) 1.05
Preimplantation diagnosis of common aneuploidies by the first- and second-polar body FISH analysis. J Assist Reprod Genet (1998) 1.05
Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations. Clin Ther (2000) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Pharmacology of calcineurin antagonists. Transplant Proc (2004) 1.04
Abasic frameshift in DNA. Solution conformation determined by proton NMR and molecular mechanics calculations. Biochemistry (1989) 1.04
Preimplantation testing for chromosomal disorders improves reproductive outcome of poor-prognosis patients. Reprod Biomed Online (2005) 1.03
Characteristics of guinea pig IgE. Int Arch Allergy Appl Immunol (1976) 1.03
Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant (2008) 1.02
Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant (2010) 1.01
Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation (2000) 1.01
Prevention of age-related aneuploidies by polar body testing of oocytes. J Assist Reprod Genet (1999) 1.01
Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation (2000) 1.00
Image engine: an integrated multimedia clinical information system. Medinfo (1995) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
The missing forgotten intrauterine contraceptive device. Contraception (1996) 0.99
African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies. Transplantation (2000) 0.98
Role of increased basal expression of heat shock protein 72 in colonic epithelial c2BBE adenocarcinoma cells. Cell Growth Differ (2001) 0.98
Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant (2010) 0.98
The medical computing "lag": perceptions of barriers to the application of computers to medicine. Int J Technol Assess Health Care (1987) 0.98
Relationship of recipient age and development of chronic allograft failure. Transplantation (2000) 0.98
Quality of cryopreserved testicular sperm in patients with obstructive and nonobstructive azoospermia. J Urol (1999) 0.96
Prolapse and elongation of the cervix during pregnancy. Int J Gynaecol Obstet (2002) 0.96
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). Am J Transplant (2013) 0.96
Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation (2001) 0.96
Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol Psychiatry (1998) 0.95
Fucosidosis type 2. Pediatrics (1976) 0.94
Acyclovir triphosphate inhibits the diagnostic polymerase chain reaction for cytomegalovirus. Transplantation (1996) 0.94
Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent. Gynecol Oncol (1985) 0.94
Oral lichen planus and squamous carcinoma. Case report and update of the literature. Arch Otolaryngol (1985) 0.93
The immediate effect of natural plant extract, Angelica sinensis and Matricaria chamomilla (Climex) for the treatment of hot flushes during menopause. A preliminary report. Clin Exp Obstet Gynecol (2003) 0.93
The grand multipara. Eur J Obstet Gynecol Reprod Biol (1995) 0.93
The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy? Transplantation (1997) 0.93
Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit (2000) 0.93
The elephant in the room: failings of current clinical endpoints in kidney transplantation. Am J Transplant (2010) 0.93
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients. Am J Transplant (2014) 0.92
PGE2 induction of labor for consistent decreased perception of fetal movements at term. Int J Gynaecol Obstet (2003) 0.92
Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc (2001) 0.91
Induction of labor with vaginal prostaglandin E2. J Matern Fetal Neonatal Med (2003) 0.91
Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant (2010) 0.90